Key Takeaways
- • Vera Health raised $28.5M in a Series A round led by Threshold Ventures, with participation from Optum Ventures, Mantis VC and SV Angel, according to the company's October 27, 2026 announcement.
- • Existing investors Y Combinator and Gradient increased their commitments in the round, bringing Vera Health's total funding to $32M to date, per company executives.
- • The clinical AI search engine scans more than 60 million peer-reviewed publications, clinical guidelines, consensus statements and drug labels, and is used by more than 800,000 clinicians in 190 countries, up from a few thousand a year ago.
- • Co-founder Taieb Bennani said Vera was the most downloaded clinical app globally across the App Store and Google Play every month since June, and that it was downloaded more in September than several of the largest players in the space combined.
- • The company will use the capital for evidence infrastructure, international expansion, partnerships and hiring, having grown its team from six to 12 people.
Summary
Vera Health, a clinical artificial intelligence search engine, secured $28.5 million in Series A funding to accelerate and expand its platform, according to the company's October 27, 2026 announcement reported by Fierce Healthcare. Threshold Ventures led the round, with participation from Optum Ventures, Mantis VC and SV Angel. Existing investors Y Combinator and Gradient also participated, with the announcement describing them as having tripled down in the round. Executives say the company has raised $32 million to date.
Emily Melton, co-founder and managing partner of Threshold Ventures, said Vera is differentiated because it starts with evidence rather than an answer, helping clinicians find and assess the research behind a decision while making its strengths and limitations visible. Melton described the platform as a potential trusted clinical intelligence layer rather than another AI tool.
Vera's platform scans more than 60 million peer-reviewed publications, clinical guidelines, consensus statements and drug labels. Co-founder Taieb Bennani told Fierce Healthcare the company's approach rests on four principles: honesty, traceability, transparency and context. Bennani emphasized that the system finds supporting evidence first and only then generates an answer, contrasting this with general-purpose language models, which he said are built to sound certain. He cited an estimated 17-year lag for new medical knowledge to reach clinical practice, according to research in the Journal of the Royal Society of Medicine.
According to Bennani, the platform is used by more than 800,000 clinicians in 190 countries, up from a few thousand a year earlier, with growth driven largely by word of mouth among clinicians rather than a large sales organization. He said Vera has been the most downloaded clinical app in the world on the App Store and Google Play every month since June. The company plans to deploy the new capital into evidence infrastructure, international expansion, partnerships and staffing, and said it has doubled its team from six to 12 people while hiring internationally.
The funding comes amid intensifying competition in clinical AI and medical search. Established clinical reference providers such as Elsevier's ClinicalKey and Wolters Kluwer's UpToDate compete with AI-native tools including OpenEvidence and Doximity Ask, as well as consumer AI developers OpenAI and Anthropic.
Emily Melton, co-founder and managing partner of Threshold Ventures, said Vera is differentiated because it starts with evidence rather than an answer, helping clinicians find and assess the research behind a decision while making its strengths and limitations visible. Melton described the platform as a potential trusted clinical intelligence layer rather than another AI tool.
Vera's platform scans more than 60 million peer-reviewed publications, clinical guidelines, consensus statements and drug labels. Co-founder Taieb Bennani told Fierce Healthcare the company's approach rests on four principles: honesty, traceability, transparency and context. Bennani emphasized that the system finds supporting evidence first and only then generates an answer, contrasting this with general-purpose language models, which he said are built to sound certain. He cited an estimated 17-year lag for new medical knowledge to reach clinical practice, according to research in the Journal of the Royal Society of Medicine.
According to Bennani, the platform is used by more than 800,000 clinicians in 190 countries, up from a few thousand a year earlier, with growth driven largely by word of mouth among clinicians rather than a large sales organization. He said Vera has been the most downloaded clinical app in the world on the App Store and Google Play every month since June. The company plans to deploy the new capital into evidence infrastructure, international expansion, partnerships and staffing, and said it has doubled its team from six to 12 people while hiring internationally.
The funding comes amid intensifying competition in clinical AI and medical search. Established clinical reference providers such as Elsevier's ClinicalKey and Wolters Kluwer's UpToDate compete with AI-native tools including OpenEvidence and Doximity Ask, as well as consumer AI developers OpenAI and Anthropic.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.